These evidences strongly demonstrated that by restraining the activation of the TGF-β signaling pathway with TMEM100, Smad2/3 phosphorylation, and phenotypic transformation of EMT process in CRC cells can be inhibited, and finally, the malignant progression of CRC can be suppressed. The gene discussed is TGFB1; the disease is colorectal carcinoma.